Found 30 matching trials
Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma PHASE2 This phase II trial studies how well dinutuximab works when given with sarg...
Show More Location
Children's Hospital of Alabama
Learn More & Join Trial
Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse PHASE1 This phase I/II trial studies the side effects and best dose of iberdomide ...
Show More Location
Multiple Locations
Learn More & Join Trial
Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma PHASE3 Neuroblastoma (NB) is a malignant neoplasm of the sympathetic nervous syste...
Show More Location
National medical research center of pediatric haematology, oncology and immulogy named after Dmytriy Rogachyov, Moscow, 117198
Learn More & Join Trial
Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas PHASE3 Data from 40 patients are planned to be included in the study to randomize ...
Show More Learn More & Join Trial
Dinutuximab-beta and Chemotherapy in Newly Diagnosed High-Risk Neuroblastoma PHASE1 This clinical trial investigates the safety, side effects, and effectivenes...
Show More Location
National Taiwan University Hospital
Learn More & Join Trial
Immunotherapy With Dinutuximab Beta in Combination With Chemotherapy for the Treatment of Patients With Primary Neuroblastoma Refractory to Standard Therapy and With Relapsed or Progressive Disease PHASE1 Safety evaluation and initial efficacy evaluation will be conducted in a gr...
Show More Location
University Children Hospital
Learn More & Join Trial
International Phase I Trial of Dinutuximab Beta With VDC/IE in GD2-Positive Ewing Sarkoma PHASE1 The goal of the study is to investigate the feasibility, toxicity, and biol...
Show More Location
Multiple Locations
Learn More & Join Trial
Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma PHASE3 The modern strategy of therapy of high-risk neuroblastoma, stage 4, consist...
Show More Location
Research Institute of Pediatric Hematology, Oncology and Immunology
Learn More & Join Trial
Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma PHASE3 This partially randomized phase III trial studies isotretinoin with dinutux...
Show More Location
Children's Hospital of Alabama
Learn More & Join Trial
Evaluation of the Safety and Pharmacokinetics of Dinutuximab Beta As Maintenance Therapy in Chinese Participants With High-Risk Neuroblastoma PHASE1 This was an open-label, multi-center, single-arm, Phase 1 study. The purpos...
Show More Location
Xinhua Hospital Affiliated To Shanghai Jiao Tong University School Of Medicine
Learn More & Join Trial